Chong P, Yang Y P, Persaud D, Haer M, Tripet B, Tam E, Sia C, Klein M
Connaught Centre for Biotechnology Research, Willowdale, Ontario, Canada.
Infect Immun. 1995 Oct;63(10):3751-8. doi: 10.1128/iai.63.10.3751-3758.1995.
To identify the B- and T-cell epitopes of P1 of Haemophilus influenzae type b, 13 peptides covering 90% of the protein were chemically synthesized. Mouse, guinea pig, and rabbit antisera raised against purified native P1 were tested for their reactivities against the peptides in peptide-specific enzyme-linked immunosorbent assays (ELISAs). Six immunodominant linear B-cell epitopes were mapped to residues 103 to 137, 189 to 218, 248 to 283, 307 to 331, 384 to 412, and 400 to 437 of the mature P1 protein. When P1 peptides were screened for their reactivities with three human convalescent-phase serum specimens, peptides corresponding to residues 39 to 64, 226 to 253, and 400 to 437 reacted strongly with the antisera. Four regions (residues 39 to 64, 226 to 253, 339 to 370, and 400 to 437) contained murine T-cell epitopes. Rabbit antipeptide antisera were tested for their reactivities with the immunizing peptides and P1 protein by ELISA and immunoblots. All anti-P1 peptide antisera except those raised against peptide HIBP1-8 (residues 279 to 312) or HIBP1-8-keyhole limpet hemocyanin conjugate were shown to be specific for their respective immunizing peptides by ELISA. In addition, rabbit antisera raised against the synthetic peptides corresponding to residues 1 to 29, 39 to 64, 103 to 137, 189 to 218, 226 to 253, 248 to 283, 307 to 331, and 400 to 437 of the mature P1 protein recognized the P1 protein from both typeable and nontypeable isolates. These results suggest that these peptides contain epitopes highly conserved among typeable and nontypeable strains of H. influenzae. However, none of the antipeptide antisera have bactericidal activity, nor were they protective against H. influenzae type b in the infant rat model of bacteremia.
为鉴定b型流感嗜血杆菌P1蛋白的B细胞和T细胞表位,化学合成了覆盖该蛋白90%的13条肽段。在肽特异性酶联免疫吸附测定(ELISA)中,检测了针对纯化天然P1蛋白制备的小鼠、豚鼠和兔抗血清与这些肽段的反应性。6个免疫显性线性B细胞表位被定位到成熟P1蛋白的第103至137位、189至218位、248至283位、307至331位、384至412位以及400至437位残基处。当用3份人类恢复期血清标本筛选P1肽段的反应性时,对应于第39至64位、226至253位以及400至437位残基的肽段与抗血清强烈反应。4个区域(第39至64位、226至253位、339至370位以及400至437位残基处)含有小鼠T细胞表位。通过ELISA和免疫印迹法检测兔抗肽抗血清与免疫肽段及P1蛋白的反应性。ELISA结果显示,除针对肽段HIBP1 - 8(第279至312位残基)或HIBP1 - 8 - 钥孔血蓝蛋白缀合物制备的抗血清外,所有抗P1肽抗血清对各自的免疫肽段具有特异性。此外,针对成熟P1蛋白第1至29位、39至64位、103至137位、189至218位、226至253位、248至283位、307至331位以及400至437位残基对应的合成肽段制备的兔抗血清,能识别可分型和不可分型菌株的P1蛋白。这些结果表明,这些肽段含有在可分型和不可分型流感嗜血杆菌菌株中高度保守的表位。然而,所有抗肽抗血清均无杀菌活性,在幼鼠菌血症模型中也不能保护其免受b型流感嗜血杆菌感染。